164 related articles for article (PubMed ID: 10066344)
1. The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.
Hühn J; Olek S; Fleischer B; von Bonin A
Cell Immunol; 1999 Feb; 192(1):33-40. PubMed ID: 10066344
[TBL] [Abstract][Full Text] [Related]
2. Specific binding of adenosine deaminase but not HIV-1 transactivator protein Tat to human CD26.
Blanco J; Marié I; Callebaut C; Jacotot E; Krust B; Hovanessian AG
Exp Cell Res; 1996 May; 225(1):102-11. PubMed ID: 8635502
[TBL] [Abstract][Full Text] [Related]
3. Binding of adenosine deaminase to the lymphocyte surface via CD26.
De Meester I; Vanham G; Kestens L; Vanhoof G; Bosmans E; Gigase P; Scharpé S
Eur J Immunol; 1994 Mar; 24(3):566-70. PubMed ID: 7907293
[TBL] [Abstract][Full Text] [Related]
4. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response.
Dong RP; Kameoka J; Hegen M; Tanaka T; Xu Y; Schlossman SF; Morimoto C
J Immunol; 1996 Feb; 156(4):1349-55. PubMed ID: 8568233
[TBL] [Abstract][Full Text] [Related]
5. Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation.
Dong RP; Tachibana K; Hegen M; Munakata Y; Cho D; Schlossman SF; Morimoto C
J Immunol; 1997 Dec; 159(12):6070-6. PubMed ID: 9550406
[TBL] [Abstract][Full Text] [Related]
6. CD26/dipeptidyl peptidase IV does not work as an adenosine deaminase-binding protein in rat cells.
Iwaki-Egawa S; Watanabe Y; Fujimoto Y
Cell Immunol; 1997 Jun; 178(2):180-6. PubMed ID: 9225009
[TBL] [Abstract][Full Text] [Related]
7. Adenosine deaminase binding to human CD26 is inhibited by HIV-1 envelope glycoprotein gp120 and viral particles.
Valenzuela A; Blanco J; Callebaut C; Jacotot E; Lluis C; Hovanessian AG; Franco R
J Immunol; 1997 Apr; 158(8):3721-9. PubMed ID: 9103436
[TBL] [Abstract][Full Text] [Related]
8. Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule.
Martín M; Huguet J; Centelles JJ; Franco R
J Immunol; 1995 Nov; 155(10):4630-43. PubMed ID: 7594462
[TBL] [Abstract][Full Text] [Related]
9. Triggering of the proteinase dipeptidyl peptidase IV (CD26) amplifies human T lymphocyte proliferation.
Bednarczyk JL; Carroll SM; Marin C; McIntyre BW
J Cell Biochem; 1991 Jul; 46(3):206-18. PubMed ID: 1723066
[TBL] [Abstract][Full Text] [Related]
10. Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase.
Sharoyan S; Antonyan A; Mardanyan S; Lupidi G; Cristalli G
Acta Biochim Pol; 2006; 53(3):539-46. PubMed ID: 16929383
[TBL] [Abstract][Full Text] [Related]
11. Purified and cell-bound CD26: enzymatic inhibition, antibody binding profile, and expression on T cells in relation to other surface markers.
Scharpe S; De Meester I
Verh K Acad Geneeskd Belg; 1994; 56(6):537-59. PubMed ID: 7892748
[TBL] [Abstract][Full Text] [Related]
12. The cysteine-rich region of dipeptidyl peptidase IV (CD 26) is the collagen-binding site.
Löster K; Zeilinger K; Schuppan D; Reutter W
Biochem Biophys Res Commun; 1995 Dec; 217(1):341-8. PubMed ID: 8526932
[TBL] [Abstract][Full Text] [Related]
13. Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase binding.
Yu DM; Slaitini L; Gysbers V; Riekhoff AG; Kähne T; Knott HM; De Meester I; Abbott CA; McCaughan GW; Gorrell MD
Scand J Immunol; 2011 Feb; 73(2):102-11. PubMed ID: 21198750
[TBL] [Abstract][Full Text] [Related]
14. Evidence that thymocyte-activating molecule is mouse CD26 (dipeptidyl peptidase IV).
Vivier I; Marguet D; Naquet P; Bonicel J; Black D; Li CX; Bernard AM; Gorvel JP; Pierres M
J Immunol; 1991 Jul; 147(2):447-54. PubMed ID: 1712807
[TBL] [Abstract][Full Text] [Related]
15. Function of dipeptidyl peptidase IV (CD26, Tp103) in transfected human T cells.
Hegen M; Camerini D; Fleischer B
Cell Immunol; 1993 Feb; 146(2):249-60. PubMed ID: 7909722
[TBL] [Abstract][Full Text] [Related]
16. CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse.
Pacheco R; Martinez-Navio JM; Lejeune M; Climent N; Oliva H; Gatell JM; Gallart T; Mallol J; Lluis C; Franco R
Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9583-8. PubMed ID: 15983379
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism and structural basis of interactions of dipeptidyl peptidase IV with adenosine deaminase and human immunodeficiency virus type-1 transcription transactivator.
Fan H; Tansi FL; Weihofen WA; Böttcher C; Hu J; Martinez J; Saenger W; Reutter W
Eur J Cell Biol; 2012 Apr; 91(4):265-73. PubMed ID: 21856036
[TBL] [Abstract][Full Text] [Related]
18. CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes.
van Lingen RG; van de Kerkhof PC; Seyger MM; de Jong EM; van Rens DW; Poll MK; Zeeuwen PL; van Erp PE
Br J Dermatol; 2008 Jun; 158(6):1264-72. PubMed ID: 18384439
[TBL] [Abstract][Full Text] [Related]
19. The significance of hypersialylation of dipeptidyl peptidase IV (CD26) in the inhibition of its activity by Tat and other cationic peptides. CD26: a subverted adhesion molecule for HIV peptide binding.
Smith RE; Talhouk JW; Brown EE; Edgar SE
AIDS Res Hum Retroviruses; 1998 Jul; 14(10):851-68. PubMed ID: 9671214
[TBL] [Abstract][Full Text] [Related]
20. Occupancy of dipeptidyl peptidase IV activates an associated tyrosine kinase and triggers an apoptotic signal in human hepatocarcinoma cells.
Gaetaniello L; Fiore M; de Filippo S; Pozzi N; Tamasi S; Pignata C
Hepatology; 1998 Apr; 27(4):934-42. PubMed ID: 9537431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
